Schmid Timothy 4

What Happened
Timothy Schmid, EVP and Worldwide Chair, MedTech at Johnson & Johnson (JNJ), sold 1,322 shares on Feb 20, 2026. The shares were reported as an open-market or private sale (code S) at $245.66 per share, for a total reported value of $324,763. This was a sale (not a purchase), which insider sales can be routine and do not by themselves signal company outlook.

Key Details

• Transaction date and price: 2026-02-20 — 1,322 shares at $245.66 per share (total $324,763).
• Transaction type: Reported as "Open market or private sale" (SEC code S).
• Shares owned after transaction: Not specified in the filing.
• Filing: Form 4 filed on 2026-02-23 (timely — within the two business-day reporting window).
• Footnotes from the filing:
  • F1: Shares held by ESOP under the Johnson & Johnson Savings Plan as of the plan’s most recent reporting date (1/31/2026).
  • F2: Includes shares accrued via dividend reinvestment in the Johnson & Johnson Stock Fund under the Savings Plan as of 1/31/2026.
• No 10b5-1 plan, tax-withholding sale, or option exercise was indicated in the reported transaction.

Context
Insider sales can occur for many personal reasons (diversification, taxes, liquidity) and are common for executives; they are not direct indicators of company performance. Purchases typically carry more weight for assessing insider conviction. This report documents a routine open-market sale by a senior J&J executive.